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Abstract
Although treatment of brain abscess requires a combination of antimicrobials and surgical intervention for the infected foci, nonsurgical,
empirical treatment is possible and efﬁcient in selected groups of patients. A total of 31 patients were enrolled in this 22-year retro-
spective study. We describe our therapeutic experiences and attempt to analyze the risk factors that were predictive of therapeutic
outcomes. Multiple logistic regression was used to evaluate the relationships between baseline clinical factors and therapeutic outcome
during the study period. Of these 31 patients, 25 had community-acquired infections, whereas the other six had nosocomially-acquired
infections. Thirteen cases (42%) had a single brain abscess and the other 18 cases (58%) had multiple brain abscesses. Furthermore, the
association of bacterial meningitis and brain abscess was found in 81% (25/31) of cases. The overall case fatality rate was 48% (15/31).
Signiﬁcant risk factors for poor outcomes included Glasgow coma scale (GCS) at presentation, presence of septic shock and neck stiff-
ness. In addition, each reduction of one point on the GCS increased the poor outcome rate by 28%. The ﬁndings of the study demon-
strate that both a higher mortality rate (48%) and worse outcomes were found in this select group of patients. Among the signiﬁcant
prognostic factors, a lower mean GCS at presentation was a major determinant of poor outcome.
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Introduction
Despite the advent of modern neurosurgical techniques, new
antibiotics and new powerful imaging technologies, brain
abscess remains a potentially fatal central nervous system
infection [1,2]. The treatment of brain abscess requires a
combination of antimicrobials, surgical intervention and erad-
ication of primary infected foci [3,4]. Nonsurgical, empirical
treatment is possible and efﬁcient in a select group of
patients (e.g. brain abscess associated with meningitis, multi-
ple deep-seated abscesses, metastatic abscess, neonates and
infants, and abscesses located in the eloquent area of the
brain or brain stem where surgical intervention would be
inappropriate), especially when the aetiological agent is
known with a reasonably high probability as a result of
positive cultures from cerebrospinal ﬂuid and /or blood, or
drainage from the ear or sinuses [3–16].
To our knowledge, clinical research about non-operative
treatment of bacterial brain abscesses are summarized under
diverse bacterial brain abscesses or case report studies [3–16],
and only one small series of clinical research has focused speciﬁ-
cally on the non-operative treatment of bacterial brain abscess
[9]. Because of the possible beneﬁts of therapeutic interven-
tion, there is a need for a better delineation of the potential risk
factors and clinical features in this speciﬁc group of patients.
In the present study, we describe our therapeutic experi-
ences and attempt to analyze the clinical features, neuroimag-
ing ﬁndings, clinical scores and measurements to determine
the therapeutic outcomes in this special group of patients.
Materials and Methods
We retrospectively reviewed the microbiological records for
abscess and blood cultures, medical records and neuroimaging
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ﬁndings, using pre-existing standardized evaluation forms,
for 205 patients with bacterial brain abscesses who were
admitted to the Department of Neurology, Kaohsiung Chang
Gung Memorial Hospital, between January 1986 and Decem-
ber 2007. Kaohsiung Chang Gung Memorial Hospital, the
largest medical center in southern Taiwan, is a 2482-bed
acute-care teaching hospital, which provides both primary and
tertiary referral care of patients.
The inclusion criteria for non-operative treatment of
bacterial brain abscesses were: (i) characteristic computer-
ized tomography (CT) and/or magnetic resonance imaging
(MRI) ﬁndings; (ii) the aetiological agent was known with a
reasonably high probability as a result of positive cultures
from cerebrospinal ﬂuid and/or blood, and/or drainage from
the ear or sinuses; and (iii) classical clinical manifestations
including headache, fever, localized neurological signs and/or
consciousness disturbance [1,2]. Patients were excluded if
the diagnosis was in doubt and if surgical treatment consisted
of either aspiration or excision of the abscess. Thus, only 31
of the 205 patients were enrolled for analysis. The study
protocol was approved by the Chang Gung Memorial Hospi-
tal Institutional Review Committee on Human Research.
All of the materials from cerebrospinal ﬂuid and/or blood,
and/or drainage from the ear or sinuses were cultured for
aerobic and anaerobic bacteria, Mycobacterium and fungi.
Antibiotic susceptibility was determined using the Kirby–Bau-
er disc diffusion method (Mueller–Hinton II agars; Becton
Dickinson Microbiology Systems, Cockeysville, MD, USA).
Patients who were initially treated at other hospitals but sub-
sequently transferred to our hospital for further therapy
were also included in this study, with initial clinical data col-
lected at those hospitals used for analysis.
Brain abscesses were deﬁned as nosocomial according to
the 1988 guidelines of the Centers for Disease Control [17].
Brain abscesses related to head trauma with skull fractures
or neurosurgical procedures were classiﬁed as a post-neuro-
surgical form. Otherwise, patients who presented with no
distinctive characteristics, and/or who had not undergone
invasive procedures, were classiﬁed as having a spontaneous
form.
The Glasgow coma scale (GCS) score was determined by
neurosurgeons or neurologists when the patient arrived at
the emergency room. All of the patients received brain CT
scans soon after arrival at the emergency room. Follow-up
brain CT scans and/or MRI were performed if clinical deteri-
oration was noted, including the acute onset of focal neuro-
logical deﬁcits, seizures or status epilepticus, and a
progressively disturbed consciousness, as well as post-neuro-
surgical procedures. Hydrocephalus was judged retrospec-
tively by a dilated temporal horn of the ventricle without
obvious brain atrophy and/or an Evan’s ratio of more than
0.3 on initial CT scans. The Evan’s ratio is the ratio of the
ventricular width of the bilateral frontal horn to the maxi-
mum biparietal diameter.
We measured the volumes of the brain abscesses on
admission CT scans. A radiologist experienced in the inter-
pretation of CT and blinded to the patients’ clinical and bio-
chemical data analyzed CT scans to conduct volumetric
measurements of brain abscess volumes. All images were
processed with the use of VITREA imaging processing software,
version 3.9.0.1 (Vital images, Minnetonka, MN, USA, running
on an off-line workstation. The volumes were calculated
using a semi-automated process. The examiner manually
drew regions-of-interest (ROI) in each slice throughout the
brain abscess. Automated threshold values, based on Houns-
ﬁeld unit measurements, were applied to differentiate haema-
toma from the skull. Contiguous voxels were automatically
summed to yield a brain abscess volume. The observer drew
the brain abscess twice, at an interval of 1 month. A trained
research assistant performed these measurements again.
Maps of the ROI used for measurement were stored and
then conﬁrmed by a neurosurgeon. Intra-observer and inter-
observer reproducibility of these measurements was evalu-
ated by using intraclass correlation coefﬁcients. For brain
abscess volume measurements, the intra-observer agreement
was r = 0.99 and the inter-observer agreement was r = 0.99.
Furthermore, the ‘volumes of brain abscesses’ indicates the
summation of all the volumes of the brain abscesses if at
least two brain abscesses were found.
The combination of third-generation cephalosporins and
metronidazole for 8–12 weeks is the mainstay of initial
empiric antimicrobial treatment for bacterial brain abscesses.
The choice of ﬁnal antibiotics was guided by the ﬁnal culture
results from the cerebrospinal ﬂuid and/or blood, and/or
drainage from the ear or sinuses. Our standard protocol was
to perform follow-up CT scans and/or MRI every 2 weeks
during hospitalization. Evaluation of therapeutic outcome
after discharge used the Glasgow outcome score (GOS) as:
good recovery, moderate disability, severe disability, persis-
tent vegetative state and death [18]. For statistical analysis, a
good recovery was deﬁned as a good outcome, whereas
moderate disability, severe disability, persistent vegetative
state and death were deﬁned as poor outcomes [19]. Two
separate statistical analyses were performed. First, the demo-
graphic data between the good and poor outcome groups
were compared. Categorical variables were compared using
a chi-square test or Fisher’s exact test. Continuous variables
within the two groups were compared using the independent
t-test for parametric data and the Mann–Whitney U-test for
nonparametric data. Second, signiﬁcant variables (p <0.05)
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found to be associated with a poor outcome were entered
into a forward stepwise logistic regression analysis model,
which allowed for simultaneous control of multiple factors.
Variables with a zero cell count in a two-by-two table were
eliminated from logistic analysis, whereas only variables with
a strong association with fatality rate (p <0.05) were
included in the ﬁnal model. All statistical tests were two-
tailed. All statistical analyses were conducted using the SAS
software, version 13.0 (SAS Statistical Institute, Cary, NC,
USA).
Results
The 31 patients included 21 males (mean age 56 years; range
31–84 years) and ten females (mean age 55 years; range 1–
74 years). Of these 31 patients, 25 had community-acquired
infections, whereas the other six were diagnosed with no-
socomially-acquired infections. The associated underlying
conditions of the 31 patients are listed in Table 1. Twenty-
two cases had more than one underlying disease, whereas
the other nine cases did not. Diabetes mellitus, alcoholism
and valvular heart diseases were the three most common
underlying conditions.
The portal of entry for infection in these 31 cases
included haematogenous spread from remote foci (e.g. hepa-
tobiliary tract, cardiopulmonary origin) in 21 cases, contigu-
ous infection from parameningeal foci (e.g. odontogenic
origin, otogenic origin or paranasal sinusitis) in four cases,
both post-neurosurgical states and haematogenous spread in
two cases, and was unknown in four cases. Causative patho-
gens were found in 23 of the 31 cases. The pathogens were
isolated from CSF cultures alone in ten cases, blood cultures
alone in ﬁve cases, both blood and CSF cultures in four
cases, and drainage from the ear or sinuses in four cases.
The other eight cases who revealed negative cultures from
both CSF and blood, had concomitant bacterial meningitis
and the diagnosis was conﬁrmed by serial neuroimaging stud-
ies under antimicrobial therapy. Sixty-one percent (61%; 19/
31) were infected by a single pathogen, with Gram-negative
bacilli being the most prevalent, followed by Staphylococcus
species and Streptococcal species. Mixed infections accounted
for 13% (4/31), in which Acinetobacter baumannii, Escherichia
coli, Enterobacter aerogenes and coagulase-negative Staphylococ-
cus, were the implicated pathogens. Twenty-six percent
(26%; 8/31) of the patients had a negative culture (Table 2).
Six patients had Klebsiella (K.) pneumoniae brain abscesses,
all of whom were diabetic and had concomitant bacterial
meningitis. Of these six patients, two had liver abscesses,
one had endophthalmitis, one had both endophthalmitis and
deltoid pyomyositis, one had purulent pericarditis, and one
had septic arthritis. One patient progressed to diabetic ke-
toacidosis. Fever, disturbed consciousness, septic shock and
headache were the four most common clinical features in
these 31 cases, accounting for 77% (24/31), 61% (19/31),
55% (17/31) and 52% (16/31), respectively. Other clinical fea-
tures, median GCS on presentation, median length of hospi-
talization (days) and median GOS at discharge are listed in
Table 3.
The neuroimaging ﬁndings of the 31 cases are listed in
Table 4. The locations of the abscesses in all 31 cases were
supratentorial. In total, 13 cases (42%) had a single brain
abscess and the other 18 cases (58%) had multiple brain
abscesses. In single brain abscesses, the most common sites
for brain abscess were the frontal lobe, temporal lobe and
basal ganglion. The left hemisphere was involved more than
TABLE 1. Underlying conditions of the study patients
Underlying conditions n = 31a
Diabetes mellitus 12
Alcoholism 7
Valvular heart disease 6
Congenital heart disease 5
End-stage renal disease 4
Liver cirrhosis 3
Chronic ototis media 3
Post-neurosurgical state 2
Atrial ﬁbrillation 2
Coronary artery diseases 2
Drug abuse 2
aTwenty-two cases had more than one underlying disease.
TABLE 2. Causative pathogens of the brain abscesses (Janu-
ary 1986 to December 2007)
Organisms
1986 through
1996 n = 6 (4)
1997 through
2007 n = 25 (11)
n = 31
(15)
Gram-negative bacilli (n = 11)
Klebsiella pneumonia 2 4(2) 6 (2)
Other Gram-negative bacilli 2 (2)a 3 (1)b 5 (3)
Staphylococcus species (n = 4)
Staphylococcus aureus 1(1) 2c 3 (1)
Staphylococcus epidermidis 0 1(1) 1 (1)
Streptococcus species (n = 3)
Viridans Streptococci 0 3 (1) 3 (1)
Anaerobic Gram-negative bacillus 1 (1)d 0 1 (1)
Mixed infections (n = 5) 0 4e(3) 4 (3)
Negative culture (n = 2) 0 8 (3)f 8 (3)
The number of deaths is given in parenthesis.
aThe causative pathogens were Escherichia coli (1) and Vibrio cholera (1).
bThe causative pathogens were Acinetobacter baumannii (1) and Escherichia coli
(1).
cThe causative pathogens included one oxacillin resistant S. aureus.
dBacteriodes vulgatus.
eAcinetobacter baumannii, Enterococcus spp.; Escherichia coli, Enterobacter aerogenes;
Staphylococcus haemolyticus, S. epidermidis, Enterococcus faecalis; Chryseobacterium
meningosepticum, S. epidermidis.
fThe eight cases had concomitant bacterial meningitis and revealed negative cul-
tures from cerebrospinal ﬂuid and/or blood, and/or drainage from the ear or
sinuses, and conﬁrmation of the diagnosis was made by serial neuroimaging
studies under antimicrobial therapy.
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the right, with nine on the left, four on the right and 18
bilaterally on both hemispheres. Other neuroimaging ﬁndings
including median volume (interquartile range) of the brain
abscesses on admission, brain abscess rupture into ventricles
and hydrocephalus are listed in Table 4.
All 31 patients received antimicrobial therapy alone, 18 of
whom had multiple pyogenic brain abscesses, and 13 were
associated with underlying systemic conditions or had con-
comitant bacterial meningitis. The overall case fatality rates
were 46% (6/13) in patients with a single brain abscess and
50% (9/18) in patients with multiple brain abscesses. In total,
16 of the 31 patients survived and the other 15 died. Thera-
peutic outcomes after discharge were determined by GOS
as nine (29%, 9/31) having a normal life, four (13%, 4/31) hav-
ing moderate disabilities, one (3.2%, 1/31) having severe dis-
abilities, two (6.5%, 2/31) persistent vegetative states, and 15
(48.3%, 15/31) deceased. The median number of hospitaliza-
tion days, acquisition of infection, types of infection, GCS
score at presentation and discharge GOS score are listed in
Table 5.
The comparative results of the clinical features and neu-
roimaging ﬁndings between patients with good and poor out-
comes are also listed in Table 5. Statistical analysis of the
clinical manifestations and laboratory data between the two
patient groups revealed signiﬁcant ﬁndings: GCS at presenta-
tion (p 0.001), presence of septic shock (p 0.0001) and neck
stiffness (p 0.045). The signiﬁcant univariate factors and pos-
sible confounding factors used in stepwise logistic regression
included GCS at presentation and the presence of neck stiff-
ness. The results revealed that, after an analysis of all the
above-mentioned variables, only GCS at presentation was
independently associated with a with poor outcome, and that
each reduction of one point on the GCS increased the poor
outcome rate by 28% (p 0.016, OR 0.717, 95% CI 0.547–
0.941).
Discussion
In clinical practice, a brain abscess rarely complicates bacte-
rial meningitis and vice versa. In addition, both conditions
can develop from contiguous or haematogenous spread from
an extradural focus. The association of bacterial brain
abscess and meningitis has been found in several situations,
including intraventricular rupture of a brain abscess, neonatal
central nervous system infections, and brain abscesses caused
by Listeria monocytogenes [20,21]. To the best of our knowl-
edge, this is the largest series study to show therapeutic
experiences among patients who received nonsurgical treat-
ment for bacterial brain abscesses. Most of our patients in
this study had associated underlying systemic conditions,
concomitant bacterial meningitis or multiple deep-seated
abscesses, where surgical intervention would be inappropri-
ate; therefore, the therapeutic outcomes were not satisfac-
tory.
In the present study, we examined the therapeutic out-
comes of non-operative treatment of bacterial brain
abscesses in selected groups of patients (e.g. brain abscess
associated with meningitis, multiple deep-seated abscesses
and metastatic abscesses). We conclude that GCS at presen-
tation, presence of septic shock and neck stiffness are risk
factors for poor outcomes, and that each reduction of one
point on the GCS increases the poor outcome rate by 28%.
Although lumbar punctures should not be performed on
patients with a proven brain abscess as a result of increased
intracranial pressure, clinicians should be aware of meningitis
as a complication of brain abscess. Surgery may be therapeu-
tic and provide tissue samples conﬁrming an infectious pro-
cess; however, isolating the causative organism from
specimens obtained during surgery has been less successful.
TABLE 4. Neuroimaging ﬁndings
n = 31
Location of abscess
Single (n = 13)
Frontal lobe 3
Temporal lobe 3
Basal ganglion 3
Temporo-parietal area 2
Occipital lobe 1
Parieto-occipital area 1
Multiple sites (n = 18) 18
Hydrocephalus 6
Rupture into ventricles 9
Median (IRQ) volumes of brain abscess (mm3)a 3 (1.3–22.2)
IQR, interquartile range.
aNeuroimaging ﬁndings at presentation.
TABLE 3. Demographic features of the study patients
n = 31
Mean age (years) 55.5 ± 17.5
Sex (male/female) 21/10
Median (IQR) GCS on presentation 9 (7, 15)
Clinical features
Fever 24
Disturbed consciousness 19
Septic shock 17
Headache 16
Neck stiffness 13
Seizure 11
Motor deﬁcitsa 10
Nausea/vomiting 10
Hydrocephalus 6
Facial palsy 2
Visual disturbance 1
Median (IQR) length of hospitalization (days) 47 (19, 68)
Median (IQR) GOS at discharge 2 (1, 5)
IQR, interquartile range; GCS, Glasgow coma scale; GOS, Glasgow outcome
score.
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In our series, 81% (25/31) of the cases were associated with
bacterial meningitis, brain abscesses with a fulminant course,
a high proportion of multiple pyogenic brain abscesses and
poor systemic conditions. Ultimately, the decision to per-
form a lumbar puncture is based on the clinical presentation.
In Taiwan, Klebsiella infection is known to commonly cause
devastating metastatic septic infection, including pyogenic
liver abscess, bacteraemia, pneumonia, endophthalmitis, brain
abscess and meningitis [22–25]. Diabetes mellitus and other
underlying diseases such as liver cirrhosis and alcoholism
appear to be predisposing factors. It has been postulated that
hyperglycaemia may enhance capsule formation and thereby
increase the virulence of the Klebsiella bacilli [23].
For patients with multiple bacterial brain abscesses, and
where the largest brain abscess is both >3 cm in diameter
and has a signiﬁcant mass effect noted in the initial CT scan,
undergoing both surgical intervention and antimicrobial
treatment is recommended [1,3,4,8]. If none of the abscesses
has a signiﬁcant mass effect, antibiotic treatment can be
used initially, with regular follow-up by CT scans to evaluate
the therapeutic response. Surgical intervention should be
performed only if either there is neurological deterioration
or if the abscess fails to resolve after antibiotic treatment.
The treatment of these patients should be judged on the
clinical status, neuroradiographic ﬁndings and the therapeutic
response, and complete resolution of abscesses for a mini-
mum of 3 months. The duration of antibiotic therapy is
dependent on the therapeutic response and neuroradio-
graphic ﬁndings, and is usually approximately 8–12 weeks
[1,3,4,8].
There are two main limitations to this retrospective study.
First, our hospital provides both primary and tertiary referral
care for patients, and several patients who were initially trea-
ted at other hospitals but subsequently transferred to our
hospital for further therapy were also included. Therefore, it
is possible that there is reporting bias due to patient selec-
tion. Second, the choice of therapeutic strategy for the bac-
terial brain abscesses was different for each patient
according to the preference of his/her doctor, and this may
have caused a potential bias in the statistical analysis.
In summary, the present study demonstrates a high mor-
tality rate (48%) and worse outcome in this special group of
TABLE 5. Prognostic factors of the study patients
Good outcome,
n = 9
Poor outcome,
n = 22 Crude OR (95% CI) p-value
Adjusted
OR (95%CI) p-value
Sex (male/female) 7/2 14/8 0.6 (0.13–2.81) 0.711 – –
Mean age at onset 48.2 ± 23.4 58.5 ± 13.9 0.139 – –
Median (IQR) GCS on presentation 15 (12, 15) 8 (6, 15) 0.001 0.717 (0.547–0.941) 0.016
Neuroimaging ﬁndings at presentation
Multiple/single 5/4 13/9 1.16 (0.24–5.53) 1.0 – –
Involved left hemisphere 5 17 2.72 (0.52–14.17) 0.385 – –
IVROBA 3 6 0.75 (0.14–4.0) 1.0 – –
Hydrocephalus 2 4 0.78 (0.12–5.25) 1.0 – –
Multiloculated 1 3 1.26 (0.11–14.05) 1.0 – –
Median (IRQ) volumes of brain abscess (mm3) 2.9 (0.54–4.7) 93.9 (1.6–24.4) 0.238 – –
Acquisition of infection
Nosocomially acquired/community acquired 1/8 5/17 2.35 (0.24–23.60) 0.642 – –
Types of infection
Post-neurosurgery/spontaneous 0/9 1/21 0.7 (0.55–0.89) 1.0 – –
Underlying diseases
Diabetes mellitus 2 10 2.92 (0.49–17.32) 0.418 – –
Chronic alcoholism 1 6 3.0 (0.31–29.35) 0.639 – –
Valve heart disease 1 5 2.35 (0.24–23.60) 0.642 – –
End-stage renal disease 0 4 0.67 (0.51–0.87) 0.295 – –
Chronic otitis media 0 3 0.68 (0.53–0.88) 0.537 – –
Liver cirrhosis 1 2 0.8 (0.06–10.11) 1.0 – –
Neoplasm 0 2 0.69 (0.54–0.88) 1.0 – –
Drug abuse 1 1 0.38 (0.02–6.85) 0.5 – –
Clinical features following brain abscess
Fever/chills 7 16 0.76 (0.12–4.75) 1.0 – –
Septic shock 0 17 0.36 (0.18–0.72) 0.0001 –a –a
Headache 7 9 0.20 (0.03–1.18) 0.113 – –
Nausea/vomiting 5 5 0.24 (0.05–1.23) 0.105 – –
Hemiparesis 2 8 2.0 (0.33–12.05) 0.677 – –
Facial palsy 1 1 0.38 (0.02–6.85) 0.503 – –
Sensory disturbance 0 1 0.7 (0.55–0.89) 1.0 – –
Neck stiffness 1 12 9.6 (1.02–90.34) 0.045 8.2 (0.74–90.58) 0.086
Visual disturbance 0 1 0.7 (0.55–0.89) 1.0 – –
Concomitant with bacterial meningitis 7 18 1.29 (0.19–8.67) 1.0 – –
Outcome
Median (IRQ) hospitalization days 53 (41–84) 44 (8–64) 0.391 – –
Mean GOS at discharge 5.0 1.7 ± 1.2 0.001 – –
IVROBA, intraventricular rupture of brain abscess; GOS, Glasgow outcome scale; GCS, Glasgow coma scale; IQR, interquartile range.
aVariables with a zero cell count in a two-by-two table were eliminated from the logistic analysis.
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patients. Among the signiﬁcant prognostic factors, a lower
mean GCS at presentation was a major determinant of poor
outcome. Regardless of the high fatality rate, early diagnosis,
the timely use of appropriate antibiotics based on antimicro-
bial susceptibility testing and correct metabolic derangement
are essential for survival.
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